Family-based exposure and response prevention therapy for preschool-aged children with obsessive-compulsive disorder: A pilot randomized controlled trial

被引:67
|
作者
Lewin, Adam B. [1 ,2 ,3 ]
Park, Jennifer M. [2 ]
Jones, Anna M. [2 ]
Crawford, Erika A. [1 ]
De Nadai, Alessandro S. [2 ]
Menzel, Jessie [2 ]
Arnold, Elysse B. [1 ,2 ]
Murphy, Tanya K. [1 ,3 ]
Storch, Eric A. [1 ,2 ,3 ]
机构
[1] Univ S Florida, Dept Pediat, St Petersburg, FL 33701 USA
[2] Univ S Florida, Dept Psychol, St Petersburg, FL 33701 USA
[3] Univ S Florida, Dept Psychiat & Behav Neurosci, St Petersburg, FL 33701 USA
关键词
OCD; Exposure-response prevention; Very young children; Accommodation; Cognitive therapy; Preschool; COGNITIVE-BEHAVIORAL THERAPY; YOUNG-CHILDREN; DEVELOPMENTAL CONSIDERATIONS; EARLY INTERVENTION; CHILDHOOD ANXIETY; PARENT; YOUTH; ACCOMMODATION; ADOLESCENTS; RELIABILITY;
D O I
10.1016/j.brat.2014.02.001
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Aims: To examine the feasibility, acceptability and preliminary efficacy of family-based exposure/response prevention therapy (E/RP) versus treatment as usual (TAU) in a cohort of very young children with early onset obsessive-compulsive disorder (OCD). Methods: Thirty-one children ages 3-8 years (M = 5.8 years) with a primary diagnosis of OCD were randomized to E/RP or TAU. The E/RP condition received 12 sessions of family-based E/RP twice weekly over 6 weeks. Families were assessed at baseline, post-treatment, 1-month and 3-month follow up. The Children's Yale Brown Obsessive Compulsive Scale and Clinical Global Impression served as primary outcome measures. Results: A large group effect emerged in favor of the E/RP group (d = 1.69). Sixty-five percent of the E/RP group was considered treatment responders as compared to 7% in the TAU group. Symptom remission was achieved in 35.2% of the E/RP group and 0% of the TAU group. There was no attrition and satisfaction was high; gains were maintained at 3 months. Conclusions: Even amongst children as young as 3 years, developmentally tailored E/RP is efficacious and well-tolerated in reducing OCD symptoms. Key adaptations for younger children include extensive parent involvement, targeting family accommodation, and frequent meetings while delivering a full course of E/RP. ClinicalTrials.gov Identifier: NCT01447966 http://clinicaltrials.gov/ct2/show/NCT01447966?term=ocd+and+st+petersburg82rank=1 (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:30 / 38
页数:9
相关论文
共 50 条
  • [21] Sertraline in children and adolescents with obsessive-compulsive disorder - A multicenter randomized controlled trial
    March, JS
    Biederman, J
    Wolkow, R
    Safferman, A
    Mardekian, J
    Cook, EH
    Cutler, NR
    Dominguez, R
    Ferguson, J
    Muller, B
    Riesenberg, R
    Rosenthal, M
    Sallee, FR
    Wagner, KD
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (20): : 1752 - 1756
  • [22] Fluvoxamine for children and adolescents with obsessive-compulsive disorder: A randomized, controlled, multicenter trial
    Riddle, MA
    Reeve, EA
    Yaryura-Tobias, JA
    Yang, HM
    Claghorn, JL
    Gaffney, G
    Greist, JH
    Holland, D
    McConville, BJ
    Pigott, T
    Walkup, JT
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2001, 40 (02): : 222 - 229
  • [23] Cognitive-coping therapy for obsessive-compulsive disorder: A randomized controlled trial
    Ma, Jian-Dong
    Wang, Chang-Hong
    Li, Heng-Fen
    Zhang, Xiao-Li
    Zhang, Ying-Li
    Hou, Yong-Hua
    Liu, Xian-Hua
    Hu, Xian-Zhang
    JOURNAL OF PSYCHIATRIC RESEARCH, 2013, 47 (11) : 1785 - 1790
  • [24] Virtual reality exposure and response prevention in the treatment of obsessive-compulsive disorder in patients with contamination subtype in comparison with in vivo exposure therapy: a randomized clinical controlled trial
    Razieh Javaherirenani
    Seyede Salehe Mortazavi
    Mohammadreza Shalbafan
    Ahmad Ashouri
    Abbas Ramezani Farani
    BMC Psychiatry, 22
  • [25] Virtual reality exposure and response prevention in the treatment of obsessive-compulsive disorder in patients with contamination subtype in comparison with in vivo exposure therapy: a randomized clinical controlled trial
    Javaherirenani, Razieh
    Mortazavi, Seyede Salehe
    Shalbafan, Mohammadreza
    Ashouri, Ahmad
    Farani, Abbas Ramezani
    BMC PSYCHIATRY, 2022, 22 (01)
  • [26] Mixed results for exposure and response prevention therapy in mixed reality for patients with contamination-related obsessive-compulsive disorder: A randomized controlled pilot study
    Miegel, Franziska
    Jelinek, Lena
    Moritz, Steffen
    Lohse, Luzie
    Yassari, Amir H.
    Buecker, Lara
    JOURNAL OF CLINICAL PSYCHOLOGY, 2023, 79 (10) : 2317 - 2336
  • [27] Family-based cognitive behavioural therapy versus family-based relaxation therapy for obsessive-compulsive disorder in children and adolescents (the TECTO trial): a statistical analysis plan for the randomised clinical trial
    Markus Harboe Olsen
    Julie Hagstrøm
    Nicole Nadine Lønfeldt
    Camilla Uhre
    Valdemar Uhre
    Linea Pretzmann
    Sofie Heidenheim Christensen
    Christine Thoustrup
    Nicoline Løcke Jepsen Korsbjerg
    Anna-Rosa Cecilie Mora-Jensen
    Melanie Ritter
    Janus Engstrøm
    Jane Lindschou
    Hartwig Roman Siebner
    Frank Verhulst
    Pia Jeppesen
    Jens Richardt Møllegaard Jepsen
    Signe Vangkilde
    Per Hove Thomsen
    Katja Hybel
    Line Katrine Harder Clemmesen
    Christian Gluud
    Kerstin Jessica Plessen
    Anne Katrine Pagsberg
    Janus Christian Jakobsen
    Trials, 23
  • [28] Predictors of response to exposure and response prevention-based cognitive behavioral therapy for obsessive-compulsive disorder
    Sayo Hamatani
    Aki Tsuchiyagaito
    Masato Nihei
    Yuta Hayashi
    Tokiko Yoshida
    Jumpei Takahashi
    Sho Okawa
    Honami Arai
    Maki Nagaoka
    Kazuki Matsumoto
    Eiji Shimizu
    Yoshiyuki Hirano
    BMC Psychiatry, 20
  • [29] Predictors of response to exposure and response prevention-based cognitive behavioral therapy for obsessive-compulsive disorder
    Hamatani, Sayo
    Tsuchiyagaito, Aki
    Nihei, Masato
    Hayashi, Yuta
    Yoshida, Tokiko
    Takahashi, Jumpei
    Okawa, Sho
    Arai, Honami
    Nagaoka, Maki
    Matsumoto, Kazuki
    Shimizu, Eiji
    Hirano, Yoshiyuki
    BMC PSYCHIATRY, 2020, 20 (01)
  • [30] A pilot randomized controlled trial of videoconference-assisted treatment for obsessive-compulsive disorder
    Vogel, Patrick A.
    Solem, Stian
    Hagen, Kristen
    Moen, Erna M.
    Launes, Gunvor
    Haland, Ashild T.
    Hansen, Bjarne
    Himle, Joseph A.
    BEHAVIOUR RESEARCH AND THERAPY, 2014, 63 : 162 - 168